Faisal Khurshid
Stock Analyst at Jefferies
(4.97)
# 69
Out of 4,673 analysts
246
Total ratings
66.7%
Success rate
76.5%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Maintained: Buy | $8 | $4.87 | +64.27% | 1 | Aug 18, 2026 | |
| INSM Insmed | Maintained: Buy | $160 → $175 | $128.32 | +36.38% | 6 | Aug 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $330 → $230 | $224.60 | +2.40% | 2 | Jul 31, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintained: Buy | $25 | $15.38 | +62.55% | 1 | Jul 31, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $17 → $15 | $12.78 | +17.37% | 4 | Jul 24, 2026 | |
| ONC BeOne Medicines AG | Upgraded: Buy | $333 → $380 | $362.51 | +4.82% | 3 | Jul 12, 2026 | |
| ABVX ABIVAX Société Anonyme | Upgraded: Buy | $90 → $158 | $120.73 | +30.87% | 4 | Jul 1, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $29 → $30 | $23.09 | +29.93% | 2 | Jun 30, 2026 | |
| VSTM Verastem | Maintained: Buy | $15 → $8 | $7.18 | +11.42% | 2 | Jun 23, 2026 | |
| PTCT PTC Therapeutics | Upgraded: Buy | $76 → $85 | $72.88 | +16.63% | 2 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 | $247.40 | +17.22% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $37 | $19.76 | +87.25% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $212.00 | -33.96% | 2 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $14.55 | +44.38% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $120 | $76.00 | +57.89% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $37.87 | +45.23% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $123.50 | -23.89% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $9.25 | +94.59% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $121.41 | -9.40% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $35.05 | -5.85% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $15.10 | -0.66% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $115.44 | +23.01% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $14.53 | +44.53% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $11.20 | -64.29% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $27.17 | -55.83% | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $27.52 | +45.35% | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.90 | +130.77% | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.5189 | - | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.00 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.68 | - | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.48 | - | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.03 | - | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $158.62 | - | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $104.60 | - | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $7.39 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.53 | n/a | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $4.36 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.10 | n/a | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.66 | n/a | 1 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.8807 | n/a | 7 | Nov 9, 2023 |
EyePoint
Aug 18, 2026
Maintained: Buy
Price Target: $8
Current: $4.87
Upside: +64.27%
Insmed
Aug 6, 2026
Maintained: Buy
Price Target: $160 → $175
Current: $128.32
Upside: +36.38%
Alnylam Pharmaceuticals
Jul 31, 2026
Maintained: Hold
Price Target: $330 → $230
Current: $224.60
Upside: +2.40%
Monte Rosa Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $25
Current: $15.38
Upside: +62.55%
Summit Therapeutics
Jul 24, 2026
Maintained: Hold
Price Target: $17 → $15
Current: $12.78
Upside: +17.37%
BeOne Medicines AG
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $362.51
Upside: +4.82%
ABIVAX Société Anonyme
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $120.73
Upside: +30.87%
Viridian Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $29 → $30
Current: $23.09
Upside: +29.93%
Verastem
Jun 23, 2026
Maintained: Buy
Price Target: $15 → $8
Current: $7.18
Upside: +11.42%
PTC Therapeutics
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $72.88
Upside: +16.63%
May 6, 2026
Maintained: Buy
Price Target: $290
Current: $247.40
Upside: +17.22%
May 1, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $19.76
Upside: +87.25%
Apr 10, 2026
Maintained: Buy
Price Target: $140
Current: $212.00
Upside: -33.96%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $14.55
Upside: +44.38%
Mar 25, 2026
Maintained: Buy
Price Target: $103 → $120
Current: $76.00
Upside: +57.89%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $37.87
Upside: +45.23%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $123.50
Upside: -23.89%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $9.25
Upside: +94.59%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $121.41
Upside: -9.40%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $35.05
Upside: -5.85%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $15.10
Upside: -0.66%
Dec 15, 2025
Maintained: Buy
Price Target: $142
Current: $115.44
Upside: +23.01%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $14.53
Upside: +44.53%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $11.20
Upside: -64.29%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $27.17
Upside: -55.83%
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $27.52
Upside: +45.35%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.90
Upside: +130.77%
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.5189
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.00
Upside: -
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.68
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.48
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.03
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $158.62
Upside: -
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $104.60
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $4 → $2
Current: $7.39
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.53
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $4.36
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $1.10
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $76.66
Upside: n/a
Nov 9, 2023
Reiterated: Hold
Price Target: $2
Current: $0.8807
Upside: n/a